Delivery Order SPE2DB22D1202-SPE2DB25FVER6
Award Date 7/15/25
Potential Completion Date 7/16/25
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The federal contract award is for the delivery of Ondansetron ODT 8 mg tablets in quantities of 30 to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $1,647.94 and is a firm fixed-price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp also holds a...
- This federal contract award is for the delivery of Ondansetron HCL 8 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $4,368.15. The contract is a delivery order with a firm fixed price pricing type, with an ultimate completion date of May 28, 2025. There is no set-aside designation mentioned for this contract....
- This federal contract award is for the delivery of Ondansetron ODT 8 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $4,022.65 and an ultimate completion date of December 19, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This appears to be a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside....
- This federal contract award is for the delivery of 4,566,790,448 units of Ondansetron HCL 4 mg tablets in 30-count packages. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,713.75 and is a Firm Fixed Price Delivery Order type. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a Delivery Order valued at $2,154.60 for the supply of Ondansetron ODT 8 mg tablets. The prime contractor is AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 11, 2025 and is a Firm Fixed Price agreement. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
- This federal contract award is for the delivery of Ondansetron HCl 8 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $15,314.72, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 6, 2024, and was awarded on February 5, 2024. This appears to be a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is...
- This federal contract award is for the delivery of Ondansetron HCL 8 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $3,950.88, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of August 5, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award is for the delivery of Ondansetron HCL 4 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $17,460.11 and is a firm fixed-price delivery order, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 24, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial Indefinite...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order for the supply of Ondansetron HCL 8 mg tablets. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm-fixed price of $24,597.35 and a period of performance through October 27, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
- This federal contract award is for the delivery of Ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,274.24 and runs through March 1, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company...